Literature DB >> 10328748

New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system.

J P Uetrecht1.   

Abstract

Mesh：

Year:  1999        PMID： 10328748     DOI： 10.1021/tx980249i

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN： 0893-228X            Impact factor:   3.739


× No keyword cloud information.
  37 in total

Review 1.  Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2010-06-10       Impact factor: 4.849

Review 2.  Reactive metabolites and adverse drug reactions: clinical considerations.

Authors:  Sandra R Knowles; Lori E Shapiro; Neil H Shear
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

Review 3.  Molecular mechanisms underlying chemical liver injury.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Expert Rev Mol Med       Date:  2012-02-03       Impact factor: 5.600

Review 4.  Cytochrome P450s and other enzymes in drug metabolism and toxicity.

Authors:  F Peter Guengerich
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

5.  The combination of nuclear and mitochondrial mutations as a risk factor for idiosyncratic toxicity.

Authors:  Daria LaRocca; David F Lehmann; Andras Perl; Takayuki Ozawa; Peter D Holohan
Journal:  Br J Clin Pharmacol       Date:  2006-08-30       Impact factor: 4.335

Review 6.  Mechanisms of drug toxicity and relevance to pharmaceutical development.

Authors:  F Peter Guengerich
Journal:  Drug Metab Pharmacokinet       Date:  2010-10-22       Impact factor: 3.614

7.  Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications.

Authors:  Wanji Seo; Alexandr A Kapralov; Galina V Shurin; Michael R Shurin; Valerian E Kagan; Alexander Star
Journal:  Nanoscale       Date:  2015-05-21       Impact factor: 7.790

8.  Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.

Authors:  Allen D Brinker; Jenna Lyndly; Joseph Tonning; David Moeny; Jonathan G Levine; Mark I Avigan
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

Review 9.  Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.

Authors:  Barbara L F Kaplan; Jinze Li; John J LaPres; Stephen B Pruett; Peer W F Karmaus
Journal:  Toxicol Sci       Date:  2015-06       Impact factor: 4.849

10.  Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor.

Authors:  Yan Jin; Arie Regev; Jeanelle Kam; Krista Phipps; Claire Smith; Judith Henck; Kristina Campanale; Leijun Hu; D Greg Hall; Xiao Yan Yang; Masako Nakano; Terry Ann McNearney; Jack Uetrecht; William Landschulz
Journal:  Br J Clin Pharmacol       Date:  2017-10-08       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.